Global Anti-depressant Drugs Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI699550
  • May 03, 2019
  • Global
  • 92 pages
  • QY Market Research
                                              "The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Anti-depressant Drugs market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Anti-depressant Drugs market."
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive“compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others)

The global Anti-depressant Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-depressant Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-depressant Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    ALKERMES PLC
    ALLERGAN PLC
    BRISTOL MYERS SQUIBB COMPANY
    ELI LILLY AND COMPANY
    GLAXOSMITHKLINE INC.
    H. LUNDBECK A/S
    MERCK INC.
    PFIZER INC.
    TEVA PHARMACEUTICAL INDUSTRIES LTD.
    TAKEDA PHARMACEUTICAL INC.

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Tricyclic Antidepressants
    Selective Serotonin Reuptake Inhibitors
    Serotonin-Norepinephrine Reuptake Inhibitors
    Monoamine Oxidase Inhibitors
    Serotonin Antagonist
    Reuptake Inhibitors
    Others

Segment by Application
    Major Depressive Disorder
    Obsessive-Compulsive Disorder
    Generalized Anxiety Disorder
    Panic Disorder
    Others
 

Table of Contents

Executive Summary
1 Anti-depressant Drugs Market Overview
    1.1 Product Overview and Scope of Anti-depressant Drugs
    1.2 Anti-depressant Drugs Segment by Type
        1.2.1 Global Anti-depressant Drugs Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Tricyclic Antidepressants
        1.2.3 Selective Serotonin Reuptake Inhibitors
        1.2.4 Serotonin-Norepinephrine Reuptake Inhibitors
        1.2.5 Monoamine Oxidase Inhibitors
        1.2.6 Serotonin Antagonist
        1.2.7 Reuptake Inhibitors
        1.2.8 Others
    1.3 Anti-depressant Drugs Segment by Application
        1.3.1 Anti-depressant Drugs Consumption Comparison by Application (2014-2025)
        1.3.2 Major Depressive Disorder
        1.3.3 Obsessive-Compulsive Disorder
        1.3.4 Generalized Anxiety Disorder
        1.3.5 Panic Disorder
        1.3.6 Others
    1.4 Global Anti-depressant Drugs Market by Region
        1.4.1 Global Anti-depressant Drugs Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Anti-depressant Drugs Market Size
        1.5.1 Global Anti-depressant Drugs Revenue (2014-2025)
        1.5.2 Global Anti-depressant Drugs Production (2014-2025)

2 Global Anti-depressant Drugs Market Competition by Manufacturers
    2.1 Global Anti-depressant Drugs Production Market Share by Manufacturers (2014-2019)
    2.2 Global Anti-depressant Drugs Revenue Share by Manufacturers (2014-2019)
    2.3 Global Anti-depressant Drugs Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Anti-depressant Drugs Production Sites, Area Served, Product Types
    2.5 Anti-depressant Drugs Market Competitive Situation and Trends
        2.5.1 Anti-depressant Drugs Market Concentration Rate
        2.5.2 Anti-depressant Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-depressant Drugs Production Market Share by Regions
    3.1 Global Anti-depressant Drugs Production Market Share by Regions
    3.2 Global Anti-depressant Drugs Revenue Market Share by Regions ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form